Antibody data
- Antibody Data
- Antigen structure
- References [2]
- Comments [0]
- Validations
- Western blot [1]
- Immunohistochemistry [1]
- Flow cytometry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- PA5-26760 - Provider product page
- Provider
- Invitrogen Antibodies
- Product name
- GAGE7 Polyclonal Antibody
- Antibody type
- Polyclonal
- Antigen
- Synthetic peptide
- Reactivity
- Human
- Host
- Rabbit
- Isotype
- IgG
- Vial size
- 400 µL
- Concentration
- 0.5 mg/mL
- Storage
- -20° C, Avoid Freeze/Thaw Cycles
Submitted references Cancer-testis antigens are predominantly expressed in uterine leiomyosarcoma compared with non-uterine leiomyosarcoma.
Role of glutamate decarboxylase-like protein 1 (GADL1) in taurine biosynthesis.
Iura K, Kohashi K, Yasutake N, Ishii T, Maekawa A, Bekki H, Otsuka H, Yamada Y, Yamamoto H, Ohishi Y, Matsumoto Y, Iwamoto Y, Oda Y
Oncology letters 2018 Jan;15(1):441-446
Oncology letters 2018 Jan;15(1):441-446
Role of glutamate decarboxylase-like protein 1 (GADL1) in taurine biosynthesis.
Liu P, Ge X, Ding H, Jiang H, Christensen BM, Li J
The Journal of biological chemistry 2012 Nov 30;287(49):40898-906
The Journal of biological chemistry 2012 Nov 30;287(49):40898-906
No comments: Submit comment
Supportive validation
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Western blot analysis using a GAGE7 polyclonal antibody (Product # PA5-26760) in K562 cell lysates (35 µg per lane).
Supportive validation
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Immunohistochemistry analysis in formalin-fixed, paraffin-embedded human prostate carcinoma using a GAGE7 polyclonal antibody (Product # PA5-26760), followed by HRP-conjugated secondary antibody and DAB staining.
Supportive validation
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Flow cytometry analysis of K562 cells using a GAGE7 polyclonal antibody (Product # PA5-26760) (right) compared to a negative control cell (left) at a dilution of 1:10-50, followed by a FITC-conjugated goat anti-rabbit antibody